c-Cbl expression as a novel predictive marker of survival in patients with metastatic colorectal cancer.

Shin Yin Lee, Vijaya B. Kolachalama, Ümit Tapan, Janice Weinberg, Jean Francis, Qing Zhao, Kevan L. Hartshorn, Nader Rahimi, Vipul C. ChitaliaJournal of Clinical Oncology 2017 · DOI

Abstract

e15090 Background: Aberrant hyperactive Wnt/ß-catenin signaling is critical in colorectal cancer (CRC) tumorigenesis. Casitas B-lineage Lymphoma (c-Cbl) is a negative regulator of Wnt signaling, and functions as a tumor suppressor. The objective of this study was to evaluate c-Cbl expression as a predictive marker of survival in patients with metastatic CRC (mCRC). Methods: Patients with mCRC treated at Boston University Medical Center between 2004 and 2014 were analyzed. c-Cbl and nuclear ß-catenin expression was quantified in explanted biopsies using a customized color-based image segmentation pipeline. Quantification was normalized to the total tumor area in an image, and deemed ‘low’ or ‘high’ according to the mean normalized values of the cohort. A supervised machine-learning model based on bootstrap aggregating was constructed with c-Cbl expression as the input feature and 3-year survival as output. Results: Of the 72 subjects with mCRC, 52.78% had high and 47.22% had low c-Cbl expression. Patients with high c-Cbl had significantly better median overall survival than those with low c-Cbl expression (3.7 years vs. 1.8 years; p = 0.0026), and experienced superior 3-year survival (47.37% vs 20.59%; p = 0.017). Intriguingly, nuclear ß-catenin expression did not correlate with survival. No significant differences were detected between high and low c-Cbl groups in baseline characteristics (demographics, comorbidities), tumor-related parameters (primary tumor location, number of metastasis, molecular features) or therapy received (surgery, chemotherapy regimen). A 5-fold cross-validated machine-learning model associated with 3-year survival demonstrated an area under the curve of 0.729, supporting c-Cbl expression as a predictor of mCRC survival. Conclusions: Our results show that c-Cbl expression is associated with and predicts mCRC survival. Demonstration of these findings despite the small cohort size underscores the power of quantitative histology and machine-learning application. While further work is needed to validate c-Cbl as a novel biomarker of mCRC survival, this study supports c-Cbl as a regulator of Wnt/ß-catenin signaling and a suppressor of other oncogenes in CRC tumorigenesis.
BibTeX
@article{lee2017c,
  author = {Shin Yin Lee and Vijaya B. Kolachalama and Ümit Tapan and Janice Weinberg and Jean Francis and Qing Zhao and Kevan L. Hartshorn and Nader Rahimi and Vipul C. Chitalia},
  title = {{c-Cbl expression as a novel predictive marker of survival in patients with metastatic colorectal cancer.}},
  journal = {Journal of Clinical Oncology},
  year = {2017},
  doi = {10.1200/jco.2017.35.15\_suppl.e15090},
}

Loading related content...

Figure